Literature DB >> 21151792

Orthotopic Liver Transplantation in Children With Hepatic-Based Metabolic Disease.

B J Zitelli1, J J Malatack, J C Gartner, B W Shaw, S Iwatsuki, T E Starzl.   

Abstract

Entities:  

Year:  1983        PMID： 21151792      PMCID： PMC3000126     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  5 in total

1.  Homotransplantation of the liver in a patient with hepatoma and hereditary tyrosinemia.

Authors:  R O Fisch; E R McCabe; D Doeden; L J Koep; J G Kohlhoff; A Silverman; T E Starzl
Journal:  J Pediatr       Date:  1978-10       Impact factor: 4.406

2.  Metabolic effects of hepatic replacement in Wilson's disease.

Authors:  C G Groth; R S Dubois; J Corman; A Gustafsson; S Iwatsuki; D O Rodgerson; C G Halgrimson; T E Starzl
Journal:  Transplant Proc       Date:  1973-03       Impact factor: 1.066

3.  Liver transplantation for advanced liver disease with alpha-1-antitrypsin deficiency.

Authors:  J M Hood; L J Koep; R L Peters; G P Schröter; R Weil; A G Redeker; T E Starzl
Journal:  N Engl J Med       Date:  1980-01-31       Impact factor: 91.245

4.  Liver transplantation with use of cyclosporin a and prednisone.

Authors:  T E Starzl; G B Klintmalm; K A Porter; S Iwatsuki; G P Schröter
Journal:  N Engl J Med       Date:  1981-07-30       Impact factor: 91.245

5.  A neurovisceral storage disease with vertical supranuclear ophthalmoplegia, and its relationship to Niemann-Pick disease. A report of nine patients.

Authors:  B G Neville; B D Lake; R Stephens; M D Sanders
Journal:  Brain       Date:  1973       Impact factor: 13.501
  5 in total
  11 in total

Review 1.  Enzyme-replacement therapy: problems and prospects.

Authors:  B Rademaker; J Raber
Journal:  Pharm Weekbl Sci       Date:  1989-10-20

Review 2.  Changing concepts: liver replacement for hereditary tyrosinemia and hepatoma.

Authors:  T E Starzl; B J Zitelli; B W Shaw; S Iwatsuki; J C Gartner; R D Gordon; J J Malatuck; I J Fox; A H Urbach; D H Van Thiel
Journal:  J Pediatr       Date:  1985-04       Impact factor: 4.406

3.  Progression of neurovisceral storage disease with supranuclear ophthalmoplegia following orthotopic liver transplantation.

Authors:  J C Gartner; I Bergman; J J Malatack; B J Zitelli; R Jaffe; J B Watkins; B W Shaw; S Iwatsuki; T E Starzl
Journal:  Pediatrics       Date:  1986-01       Impact factor: 7.124

Review 4.  Clinical considerations in orthotopic liver transplantation.

Authors:  A G Tzakis; R D Gordon; L Makowka; C O Esquivel; S Todo; S Iwatsuki; T E Starzl
Journal:  Radiol Clin North Am       Date:  1987-03       Impact factor: 2.303

5.  Liver transplantation for type I glycogen storage disease.

Authors:  J J Malatack; D N Finegold; S Iwatsuki; B W Shaw; J C Gartner; B J Zitelli; T Roe; T E Starzl
Journal:  Lancet       Date:  1983-05-14       Impact factor: 79.321

6.  Intractable neurological Wilson's disease treated with orthotopic liver transplantation.

Authors:  A L Mason; W Marsh; D H Alpers
Journal:  Dig Dis Sci       Date:  1993-09       Impact factor: 3.199

7.  Orthotopic liver transplantation in children: two-year experience with 47 patients.

Authors:  J C Gartner; B J Zitelli; J J Malatack; B W Shaw; S Iwatsuki; T E Starzl
Journal:  Pediatrics       Date:  1984-07       Impact factor: 7.124

8.  Does previous abdominal surgery alter the outcome of pediatric patients subjected to orthotopic liver transplantation?

Authors:  V Cuervas-Mons; A Rimola; D H Van Thiel; J S Gavaler; R R Schade; T E Starzl
Journal:  Gastroenterology       Date:  1986-04       Impact factor: 22.682

9.  Liver transplantation for type I and type IV glycogen storage disease.

Authors:  R Selby; T E Starzl; E Yunis; S Todo; A G Tzakis; B I Brown; R S Kendall
Journal:  Eur J Pediatr       Date:  1993       Impact factor: 3.183

Review 10.  Liver transplantation: where it's been and where it's going.

Authors:  D H Van Thiel; L Makowka; T E Starzl
Journal:  Gastroenterol Clin North Am       Date:  1988-03       Impact factor: 3.806
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.